<?xml version="1.0" encoding="UTF-8"?>
<document id="28055971">
	<sentence id="s1" text="Progression of prostate cancer (PC) to castration-recurrent growth (CRPC) remains dependent on sustained expression and transcriptional activity of the androgen receptor (oxidation-reduction process).">
		<entity id="s1.e1" charOffset="24-30"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="171-198"
			type="GO" text="oxidation-reduction process" ontology_id="GO_0055114"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="By comparing the peptidyl-tyrosine phosphorylation-induced oxidation-reduction process-cistrome and/or transcriptome in LNCaP to those in CRPC and LuCaP35.1 tumors, we identified an 11-gene Src-regulated CRPC signature consisting of AR-dependent, AR binding site (ARBS)-associated genes whose expression is altered by DHT in LNCaP[Src527F] but not in LNCaP cells.">
		<entity id="s2.e1" charOffset="17-50"
			type="GO" text="peptidyl-tyrosine phosphorylation" ontology_id="GO_0018108"/>
		<entity id="s2.e2" charOffset="59-86"
			type="GO" text="oxidation-reduction process" ontology_id="GO_0055114"/>
		<entity id="s2.e3" charOffset="132-138"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e3" pgr="true"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="false"/>
	</sentence>
</document>
